Birmingham, West Midlands -- (SBWIRE) -- 12/31/2013 -- Value Penny Stocks issues special report on: FreeSeas Inc (NASDAQ:FREE), Hertz Global Holdings, Inc. (NYSE:HTZ), BG Medicine, Inc. (NASDAQ:BGMD), North American Palladium Ltd (USA) (NYSEMKT:PAL), Star Scientific, Inc. (NASDAQ:STSI)
FreeSeas Inc (NASDAQ:FREE) surged 10.84% after the company announced today that it will consummate the second and final tranche of the $10 million previously announced investment by Crede CG III, Ltd. (the "Investor"), a wholly-owned subsidiary of Crede Capital Group, LLC, an existing shareholder of the Company.
Mr. Ion G. Varouxakis, Chairman, President and Chief Executive Officer of the Company commented: "We are very pleased to close this transaction which injects much needed cash into the Company. The Company shall now be in a financial position to finance the dry-dockings of its fleet enabling the return to operation of the vessels at a very opportune time, as the market recovery gathers pace. This injection shall also position the Company for the acquisition of vessels that can immediately produce income. We look into the coming year with great expectations."
Hertz Global Holdings, Inc. (NYSE:HTZ) soared 7.91% hitting a new 52 week high $28.16 after the news that the company has adopted a poison pill to protect itself from an unnamed activist investor. Hertz stock was up nearly 7% in early market activity, with shares of the company opening at $27.39, higher than Monday’s closing price of $25.91 and nearly reaching its 52-week high. The company announced Monday night that it is adopting a shareholder rights plan — otherwise known as a poison pill — after observing “unusual and substantial activity” in its shares. However, Hertz said that the move is not in response to any specific takeover bid or any proposal to acquire control of the company.
BG Medicine, Inc. (NASDAQ:BGMD) rallied 5.82% against no significant news.
North American Palladium Ltd (USA) (NYSEMKT:PAL) fell -8.26% rally after the company provided an update on its drill results from the second half of its 2013 underground and surface exploration program at its Lac des Iles (“LDI”) palladium mine property in Northern Ontario. The company provided highlights including that the surface drilling on Roby Zone northeast extension target extended a near-surface part of the zone. The extension target intersected significant palladium holes in the upper offset southeast extension. Follow up drilling has been planned for 2014 to define the geometry and extent of this new discovery.
Star Scientific, Inc. (NASDAQ:STSI) dropped -7.60% after the company announced the receipt on December 24, 2013, of a warning letter from the U.S. Food and Drug Administration (FDA) regarding two consumer products, Anatabloc® and CigRx®, which are marketed by the Company. The letter requires the Company to respond to the FDA with information and remedial steps.
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)